Deep Dives - Page 2
Ozempic in America: What’s the real impact? A survey reveals details
Diabetes and weight loss drug Ozempic has gone viral — causing a shortage. Find out its side effects, alternatives, broader impacts, and who wants it most.
Subscribe to get more updates, news, and tips straight to your inbox
Subscribe to get more updates, news, and tips straight to your inbox
Top Articles and Resources
Latest in Deep Dives - Page 2
Perceptions of AI in healthcare: What professionals and the public think
Learn about the public and professional perceptions of AI in healthcare and the validity of ChatGPT’s health advice.
Patient perspectives on new proposal to remove medical debt from credit reports
Explore the impact of medical debt on Americans and the potential relief the CFPB’s 2023 initiative to remove medical debt from credit reports could offer.
Weighing in on employee benefits: Employees demand weight loss coverage
Explore the rising demand for weight-loss drugs in health plans with insights from Tebra’s latest employee survey.
Overcoming the wage gap: Colleges where women graduates outpace men
Tebra research uncovers which institutions and fields of study results in women earning more than men in healthcare
Keeping secrets: Repercussions of hiding health concerns
Discover the underlying health issues surveyed Americans keep under wraps and the surprising risks they pose to their health and relationships.
Exploring healthcare careers: Navigating job opportunities and industry growth
Data about emerging trends and predictions of healthcare employment in the US for 2024.
New COVID-19 boosters are coming — here’s what you need to know
The FDA has approved new COVID-19 booster vaccines to target the XBB.1.5 variant — but how successful they’ll be depends on effective communication from providers.
AI vs. human predictions: Envisioning the future of healthcare
Exclusive survey: What does the future hold for AI and healthcare?
